Glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus | |
---|---|
Standards of medical care in diabetes — 2020 | Journal of the American Heart Association |
Glucagon-like peptide-1 receptor agonists and prevention of stroke systematic review of cardiovascular outcome trials with meta-analysis.
30.